Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs IBRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs IBRUTINIB: Safety Overview

Metric DASATINIB IBRUTINIB
Total FAERS Reports 30,019 75,087
Deaths Reported 2,681 12,580
Death Rate 8.9% 16.8%
Hospitalizations 6,437 24,920
Average Patient Age 56.4 yrs 71.2 yrs
% Female Patients 51.9% 39.2%
FDA Approval Date Apr 22, 2025 Aug 24, 2022
Manufacturer Zydus Pharmaceuticals USA Inc. Pharmacyclics LLC
Route ORAL ORAL
Marketing Status Prescription Prescription